When construction is completed this month, 704 QO will offer ready-to-occupy lab/office spaces for companies of all sizes. What really makes this new building stand out isn’t just the fully customizable individual lab units, but the suite of amenities that are tailored to the specific needs of emerging life science companies in the BioHealth Capital Region and the employees that work for them.
IQVIA™ (NYSE:IQV) today announced the launch of IQVIA™ Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companies. This solutions suite, supported by more than 1,000 dedicated employees, will deliver simplified operating procedures, specialized teams, and services to provide a more agile way for these innovators to reach their drug development and commercialization milestones. From initial planning to trial design and implementation to market launch and commercialization, IQVIA Biotech delivers a transparent and streamlined process with a deep foundation in science.
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for MEDI8897, an extended half-life respiratory syncytial virus (RSV) F monoclonal antibody (mAb) being developed for the prevention of lower respiratory tract infection (LRTI) caused by RSV.
VLP Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company’s VLPM01 malaria vaccine. The Phase I/IIa clinical trial will begin recruiting participants in February 2019, and is designed to assess the safety, immunogenicity and efficacy of the VLPM01 vaccine. The clinical trial will be conducted at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, MD.
Although startups based in California, New York, and Massachusetts have traditionally accounted for the majority of VC tech investment in the US, VCs are spurring other hotbeds of innovation across the country.
UMD IBBR – 9600 Gudelsky Drive, Rockville, MD 20850
February 28, 2019
Unique opportunity to meet 1:1 with multiple SBIR program managers and experts.
SCHEDULE
8:00 a.m. – 8:30 a.m. – Networking and Registration
8:30 a.m. – 12:00 p.m. – Program Overviews. Agencies represented:
NSF (National Science Foundation)
NIH NIA (National Institute on Aging)
NIH NCI (National Cancer Institute)
NIH NHLBI (National Heart, Lung, and Blood Institute)
NIH NIDA (National Institute on Drug Abuse)
US Army (invited)
12:00 p.m. – 1:00 p.m. – Networking Lunch
1:00 p.m. – 1:30 p.m. – Writing Specific Aims Page
1:30 – 2 p.m. – Writing Your Phase II Commercialization Program
2:00 – 2:30 p.m. – Q&A with All speakers
2:30 – 4:00 p.m. – 1:1 – Meetings with Program Managers*
Pre-Registration REQUIRED: RSVP by noon, February 26 at https://tinyurl.com/BHISBIR2019
No charge for entrepreneurs to attend • If seeking 1:1 meeting(s) please include organization(s) in RSVP.
*You do not have to participate in 1:1 meetings. However, to do so, you must attend the overview session in person.
Like a lot of medical practices, veterinarians seek to send patients a message when they’re due for a check-up, schedule appointments and keep track of medical records. Yet Marc Olcott sees a lot of those tasks still happening by phone or on paper, and thinks it should all be available digitally.
For the people looking to move within a thriving tech community, it’s important to be able to easily call upon the key players.
Community members gathered Wednesday night at Hood College’s Hodson Auditorium to celebrate Frederick Innovative Technology Center Inc.’s 15th anniversary.
GetWellNetwork, the Precision Engagement health care company reaching 10 million patients annually, announced today a pivotal 2018 which will propel the company into 2019 as it continues to lead the evolution of patient engagement. The company furthered global expansion efforts, made several executive hires and acquired leading digital health company HealthLoop to catalyze growth in the ambulatory space.
